Effect of probiotic supplementation in treatment of coronary heart disease
Not Applicable
- Conditions
- I25.9Coronary Heart Disease.Chronic ischaemic heart disease, unspecified
- Registration Number
- IRCT2017082733941N5
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Subjects aged 40-85 years
Patients diagnosed with type 2 diabetes and coronary heart disease
Exclusion Criteria
Consuming probiotic and/or synbiotic within three months prior to the intervention
Taking prebiotic, antioxidant and/or anti-inflammatory supplements such as vitamin E, vitamin C and omega-3 fatty acids
Taking antibiotics
Having an acute myocardial infarction and a cardiac surgery in the past three months
Renal or hepatic failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method